OJIM  Vol.3 No.2 , June 2013
Marked elevation of troponin I without wall motion abnormality in a patient with myocarditis: Cardiac enzymes may not predict the outcome in myocarditis
Abstract: A seventeen-year-old male presented with severe substernal chest pain after an episode of upper respiratory tract infection. On clinical grounds, a diagnosis of myocarditis was established. He had a peak troponin I level as high as 40.4 ng/dl but interestingly with no abnormal wall motion and normal ejection fraction in echocardiography. Coronary artery disease was excluded with normal coronary angiography. Diagnosis of myocarditis was confirmed with cardiac MRI. After one month, patient had no complaint and ejection fraction were still normal. Our case emphasizes that the troponin levels predict neither the early nor the late outcome of the left ventricular functions in myocarditis, therefore serum troponin I may not be helpful in determining the prognosis of patients with myocarditis.
Cite this paper: Ozkok, A. , Atakan, A. , Acar, G. , Atas, R. , Kaya, O. , Toz, B. , Kose, M. , Akpinar, T. , Tufan, F. and Oflaz, H. (2013) Marked elevation of troponin I without wall motion abnormality in a patient with myocarditis: Cardiac enzymes may not predict the outcome in myocarditis. Open Journal of Internal Medicine, 3, 50-52. doi: 10.4236/ojim.2013.32011.

[1]   Adams, J.E., Bodor, G.S., Davila-Roman, V.G., Delmez, J.A., Apple, F.S., Ladenson, J.H., et al. (1993) Cardiac troponin I: A marker with high specificity for cardiac injury. Circulation, 88, 101-106. doi:10.1161/01.CIR.88.1.101

[2]   Roongsritong, C., Warraich, I. and Bradley, C. (2004) Common causes of troponin elevations in the absence o acute myocardial infarction. Chest, 125, 1877-1884. doi:10.1378/chest.125.5.1877

[3]   Muhammad, A., Baig, et al. (2006) Cardiac troponin I release in non-ischemic reversible myocardial injury from parvovirus B19 myocarditis. International Journal of Cardiology, 113, E109-E110.

[4]   Hassan, A.K., Bergheanu, S.C., Hasan-Ali, H., Liem, S.S., van der Laarse, A., Wolterbeek, R., Atsma, D.E., Schalij, M.J. and Jukema, J.W. (2009) Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention. American Journal of Cardiology, 103, 779-784. doi:10.1016/j.amjcard.2008.11.031

[5]   Imazio, M., Cecchi, E., Demichelis, B., Chinaglia, A., Ierna, S., Demarie, D., Ghisio, A., Pomari, F., Belli, R. and Trinchero, R. (2008) Myopericarditis versus viral or idiopathic acute pericarditis. Heart, 94, 498-501. doi:10.1136/hrt.2006.104067

[6]   Imazio, M., Demichelis, B., Cecchi, E., Belli, R., Ghisio, A., Bobbio, M. and Trinchero, R. (2003) Cardiac troponin I in acute pericarditis. Journal of the American College of Cardiology, 42, 2144-2148. doi:10.1016/j.jacc.2003.02.001

[7]   Kobayashi, D., Aggarwal, S., Kheiwa, A. and Shah, N. (2012) Myopericarditis in children: Elevated troponin I level does not predict outcome. Pediatric Cardiology, 33, 1040-1045. doi:10.1007/s00246-012-0222-y

[8]   Ammann, P., Naegeli, B., Schuiki, E., Straumann, E., Frielingsdorf, J., Rickli, H. and Bertel, O. (2003) Longterm outcome of acute myocarditis is independent of cardiac enzyme release. International Journal of Cardiology, 89, 217-222. doi:10.1016/S0167-5273(02)00478-3

[9]   Smith, S.C., Ladenson, J.H., Mason, J.W. and Jaffe, A.S. (1996) Elevation of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation, 95, 163-168. doi:10.1161/01.CIR.95.1.163

[10]   Mason, J.W., O’Connell, J.B., Herskowitz, A., Rose, N.R., McManus, B.M., Billingham, M.E., et al. (1995) A clinical trial of immunosuppressive therapy for myocarditis. New England Journal of Medicine, 333, 269-275. doi:10.1056/NEJM199508033330501

[11]   Feldman, A.M. and McNamara, D. (2000) Medical progress: myocarditisitis. New England Journal of Medicine, 343, 1388-1398. doi:10.1056/NEJM200011093431908